Vanguard Personalized Indexing Management LLC Acquires 206 Shares of Xylem Inc. $XYL

Vanguard Personalized Indexing Management LLC grew its position in Xylem Inc. (NYSE:XYLFree Report) by 0.4% during the second quarter, HoldingsChannel reports. The firm owned 47,256 shares of the industrial products company’s stock after buying an additional 206 shares during the period. Vanguard Personalized Indexing Management LLC’s holdings in Xylem were worth $6,113,000 at the end of the most recent quarter.

A number of other institutional investors also recently modified their holdings of the company. Concurrent Investment Advisors LLC bought a new stake in shares of Xylem in the 2nd quarter valued at $225,000. Fifth Third Wealth Advisors LLC boosted its stake in shares of Xylem by 12.2% in the 2nd quarter. Fifth Third Wealth Advisors LLC now owns 2,476 shares of the industrial products company’s stock valued at $320,000 after purchasing an additional 270 shares during the last quarter. Natural Investments LLC boosted its stake in shares of Xylem by 1.9% in the 2nd quarter. Natural Investments LLC now owns 14,476 shares of the industrial products company’s stock valued at $1,872,000 after purchasing an additional 265 shares during the last quarter. Fulcrum Capital LLC boosted its stake in shares of Xylem by 1.9% in the 2nd quarter. Fulcrum Capital LLC now owns 58,999 shares of the industrial products company’s stock valued at $7,632,000 after purchasing an additional 1,094 shares during the last quarter. Finally, Aberdeen Group plc boosted its stake in shares of Xylem by 13.5% in the 2nd quarter. Aberdeen Group plc now owns 351,099 shares of the industrial products company’s stock valued at $45,418,000 after purchasing an additional 41,800 shares during the last quarter. 87.96% of the stock is owned by institutional investors.

Insider Activity

In other news, CAO Geri-Michelle Mcshane sold 1,000 shares of the company’s stock in a transaction on Friday, September 5th. The shares were sold at an average price of $139.96, for a total value of $139,960.00. Following the completion of the sale, the chief accounting officer owned 2,957 shares in the company, valued at $413,861.72. This represents a 25.27% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. 0.27% of the stock is currently owned by insiders.

Xylem Stock Performance

XYL opened at $146.02 on Tuesday. The company has a current ratio of 1.90, a quick ratio of 1.43 and a debt-to-equity ratio of 0.17. The company’s fifty day moving average price is $143.12 and its two-hundred day moving average price is $130.64. Xylem Inc. has a 1-year low of $100.47 and a 1-year high of $151.16. The company has a market cap of $35.54 billion, a price-to-earnings ratio of 37.93, a PEG ratio of 2.49 and a beta of 1.13.

Xylem (NYSE:XYLGet Free Report) last released its quarterly earnings data on Thursday, July 31st. The industrial products company reported $1.26 earnings per share for the quarter, topping the consensus estimate of $1.15 by $0.11. Xylem had a net margin of 10.74% and a return on equity of 10.33%. The firm had revenue of $2.30 billion for the quarter, compared to the consensus estimate of $2.20 billion. During the same quarter in the prior year, the company posted $1.09 earnings per share. The business’s revenue was up 6.1% on a year-over-year basis. Xylem has set its FY 2025 guidance at 4.700-4.850 EPS. On average, analysts expect that Xylem Inc. will post 4.65 EPS for the current fiscal year.

Xylem Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Thursday, September 25th. Stockholders of record on Thursday, August 28th were paid a $0.40 dividend. The ex-dividend date was Thursday, August 28th. This represents a $1.60 annualized dividend and a dividend yield of 1.1%. Xylem’s dividend payout ratio is presently 41.56%.

Analyst Ratings Changes

A number of equities research analysts have recently commented on the stock. Stifel Nicolaus upped their price objective on shares of Xylem from $162.00 to $175.00 and gave the company a “buy” rating in a research note on Friday, August 1st. Mizuho boosted their target price on shares of Xylem from $125.00 to $140.00 and gave the company a “neutral” rating in a research report on Friday, September 12th. Cowen reiterated a “hold” rating on shares of Xylem in a research report on Tuesday, August 26th. Wall Street Zen upgraded shares of Xylem from a “hold” rating to a “buy” rating in a research report on Saturday, August 9th. Finally, Citigroup boosted their target price on shares of Xylem from $168.00 to $173.00 and gave the company a “buy” rating in a research report on Thursday. One equities research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and five have issued a Hold rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $154.67.

Get Our Latest Stock Report on Xylem

About Xylem

(Free Report)

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.

Featured Stories

Want to see what other hedge funds are holding XYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Xylem Inc. (NYSE:XYLFree Report).

Institutional Ownership by Quarter for Xylem (NYSE:XYL)

Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.